OX-PKX is a designation for the development and outlicensing of the drug delivery platforms that were included in the acquisition of PharmaKodex. The purpose is to develop proprietary products and to offer major pharmaceutical companies innovative drug delivery technologies to improve and upgrade their products. The technologies are: I) Xerosol II) Taste Transformation III) Solid syrup and IV) Pandermal.
ÊRead more about the various technologies
Project status
Formulation phase.